Cerity Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.55M Buy
35,989
+22,783
+173% +$5.73M 0.01% 829
2025
Q4
$3.75M Buy
13,206
+679
+5% +$212K 0.01% 1059
2025
Q3
$3.87M Sell
12,527
-4,735
-27% -$1.48M 0.01% 989
2025
Q2
$5.42M Buy
17,262
+7,030
+69% +$2.03M 0.01% 766
2025
Q1
$2.69M Buy
10,232
+2,284
+29% +$618K 0.01% 986
2024
Q4
$1.96M Sell
7,948
-2,245
-22% -$565K ﹤0.01% 1115
2024
Q3
$2.37M Buy
10,193
+4,484
+79% +$921K 0.01% 1015
2024
Q2
$1.15M Buy
5,709
+2,171
+61% +$391K ﹤0.01% 1161
2024
Q1
$606K Buy
+3,538
New +$660K ﹤0.01% 1511

Other funds holding PODD

Cerity Partners's PODD Position: Q1 2026 in Review

Cerity Partners increased its Insulet (PODD) stake by 173% in Q1 2026, buying an estimated $5.73M and bringing the position to 35,989 shares worth $7.55M. The position accounts for 0.01% of the portfolio, ranked #829.

Cerity Partners first reported a position in PODD in Q1 2024 and has held it in 9 quarters since. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Cerity Partners held 35,989 shares of Insulet worth $7.55M as of Q1 2026.
  • Cerity Partners bought 22,783 Insulet shares in Q1 2026, an estimated $5.73M.
  • Insulet made up 0.01% of Cerity Partners's portfolio in Q1 2026, its #829 holding.
  • Cerity Partners first reported a position in Insulet in Q1 2024 and has held it in 9 quarters since.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.